Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On
Item 5.07. Submission of Matters to a Vote of Security Holders.
On
These matters are described in detail in the Definitive Proxy Statement.
The final results for Proposals 1, 2, 3 and 4 as set forth in the Definitive Proxy Statement are as follows:
Proposal 1 - Election of Directors
The following four (4) individuals were elected as directors, to serve until the 2022 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified with the following votes:
Name of Director Votes For Withheld Broker Non-Votes 1. Jeffrey Wolf 3,339,151 848,480 7,776,767 2. John Monahan, Ph.D. 2,833,425 1,354,206 7,776,767 3. Edward B. Smith, III 2,686,381 1,501,250 7,776,767 4. John Prendergast, Ph.D. 2,830,413 1,357,218 7,776,767
Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm
The stockholders ratified and approved the appointment of
Votes For Votes Against Abstentions Broker Non-Votes
10,127,013 1,616,102 221,283 0
Proposal 3 - Approval of our 2021 Employee Stock Purchase Plan
As further described above in Item 5.02 of this Current Report on Form 8-K, the stockholders approved and adopted the 2021 Employee Stock Plan. The results of the voting for this approved proposal were as follows:
Votes For Votes Against Abstentions Broker Non-Votes 3,146,983 926,771 113,877 7,776,767
Proposal 4 - Approval of our 2021 Subsidiaries Stock Incentive Plan
As further described above in Item 5.02 of this Current Report on Form 8-K, the stockholders approved and adopted the 2021 Subsidiaries Plan. The results of the voting for this approved proposal were as follows:
Votes For Votes Against Abstentions Broker Non-Votes 2,587,431 1,479,055 121,145 7,776,767
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. Exhibit Number Description 10.1 TheHeat Biologics, Inc. 2021 Employee Stock Purchase Plan (incorporated by reference to Exhibit A to the Definitive Proxy Statement on Schedule 14A filed with theSecurities and Exchange Commission onAugust 3, 2021 ) 10.2 TheHeat Biologics, Inc. 2021 Subsidiaries Stock Incentive Plan (incorporated by reference to Exhibit B to the Definitive Proxy Statement on Schedule 14A filed with theSecurities and Exchange Commission onAugust 3, 2021 ) 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)
© Edgar Online, source